Wu A L, Windmueller H G
J Biol Chem. 1981 Apr 25;256(8):3615-8.
Recent studies of circulating lipoproteins in man and the rat have shown that apolipoprotein B in plasma exists in two immunologically distinct forms with apparent Mr, in the rat, of approximately 335,000 (apoB335K) and 240,000 (apoB240K). With isolated, perfused organs and single and double isotope labeling methods in vivo (1979) J. Biol. Chem. 254, 7316), we have now found that the rat liver produces both apoB variants in abundance while the small intestine produces apoB240K but only trace amounts of apoB335K. The hepatic apoB335K/apoB240Kleucine incorporation ratio ranged from 0.5-1.7 under different conditions, suggesting physiological regulation of the relative amounts produced. Disappearance of both newly synthesized hepatic apoB variants from plasma followed first order kinetics. The circulating half-life of hepatic apoB335K was 2.4 times that of hepatic apoB240K, indicating independent catabolism of the two variants and consistent with the hepatic production of multiple apoB-containing lipoproteins with different metabolic properties. The half-life of apoB240K from the intestine was even shorter than that of apoB240K from the liver.
最近对人类和大鼠循环脂蛋白的研究表明,血浆中的载脂蛋白B以两种免疫上不同的形式存在,在大鼠中,其表观分子量分别约为335,000(apoB335K)和240,000(apoB240K)。利用离体灌注器官以及体内单同位素和双同位素标记方法(《生物化学杂志》,1979年,第254卷,第7316页),我们现已发现,大鼠肝脏大量产生这两种载脂蛋白B变体,而小肠产生apoB240K,但仅产生微量的apoB335K。在不同条件下,肝脏中apoB335K/apoB240K的亮氨酸掺入率在0.5至1.7之间,这表明所产生的相对量受到生理调节。新合成的肝脏载脂蛋白B两种变体从血浆中的消失遵循一级动力学。肝脏apoB335K在循环中的半衰期是肝脏apoB240K的2.4倍,这表明这两种变体的分解代谢是独立的,并且与肝脏产生具有不同代谢特性的多种含apoB脂蛋白一致。来自小肠的apoB240K的半衰期甚至比来自肝脏的apoB240K的半衰期还要短。